BON revenueFY2025$18.67M
- FY YoY
- -21.7%
- 5Y CAGR
- +0.5%
BON revenue was $18.67M for fiscal 2025 (ended Sep 30, 2025), down 21.7% from fiscal 2024. Compound annual growth was +0.5% over 5 years. It rose in 3 of the last 6 fiscal years.
Bon Natural Life Limited (BON) financials
For fiscal 2025 (ended Sep 30, 2025), Bon Natural Life Limited reported $18.67M of revenue and -$1.99M of net income.
- Revenue, FY2025
- $18.67M
- Revenue growth, YoY
- -21.7%
- Net income, FY2025
- -$1.99M
- Net margin
- -10.7%
- Free cash flow, FY2025
- $134.3K
- EPS, diluted, FY2025
- -$0.72
- Cash
- $6.27M
- Total debt
- $1.92M
- P/S
- 0.48
- Market cap
- $9.0M
FY2019FY2025
FY2019FY2025
FY2019FY2025
BON revenue and earnings growth
BON net incomeFY2025-$1.99M
BON net income was -$1.99M for fiscal 2025 (ended Sep 30, 2025), compared with $398.2K in fiscal 2024.
BON EPSFY2025-$0.72
BON diluted EPS was -$0.72 for fiscal 2025 (ended Sep 30, 2025).
BON free cash flowFY2025$134.3K
- 5Y CAGR
- -44.8%
BON free cash flow was $134.3K for fiscal 2025 (ended Sep 30, 2025), compared with -$7.73M in fiscal 2024. Compound annual growth was -44.8% over 5 years.
Income statement
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $18.67M | $23.84M | $29.52M | $29.91M | $25.49M | $18.22M | $16.40M |
| Cost of revenue | $14.79M | $16.73M | $20.68M | $20.48M | $18.38M | $13.02M | $11.11M |
| Gross profit | $3.88M | $7.11M | $8.84M | $9.42M | $7.11M | $5.20M | $5.28M |
| Research and development | $754.2K | $1.62M | $298.5K | $424.6K | $249.1K | $205.4K | $522.9K |
| Selling, general and admin | $4.31M | $3.35M | $2.31M | $2.18M | $1.32M | $1.37M | $1.31M |
| Operating income | -$1.62M | $1.87M | $5.94M | $6.60M | $5.40M | $3.47M | $3.18M |
| Interest expense | $366.2K | $303.3K | $238.2K | $446.9K | $417.3K | $329.1K | $333.2K |
| Pre-tax income | -$1.71M | $715.9K | $5.57M | $7.57M | $5.43M | $3.65M | $2.99M |
| Income tax | $339.4K | $351.2K | $1.00M | $1.27M | $820.9K | $556.3K | $427.2K |
| Net income | -$1.99M | $398.2K | $4.60M | $6.24M | $4.59M | $3.03M | $2.57M |
| EPS, basic | -$0.72 | $4.17 | $125.72 | $186.75 | $172.50 | $145.00 | $125.00 |
| EPS, diluted | -$0.72 | $4.14 | $124.92 | $185.75 | $170.00 | $145.00 | $125.00 |
| Diluted shares | 2.8M | 96,114 | 36,792 | 33,584.24 | 26,824.94 | 20,842.596 | 20,666.668 |
Balance sheet
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $6.27M | $658.6K | $112.8K | $840.9K | $1.90M | $53.1K | - |
| Short-term investments | - | - | $65 | - | $1.70M | - | - |
| Receivables | $11.01M | $11.78M | $4.60M | $6.78M | $6.15M | $5.77M | - |
| Inventory | $3.31M | $1.57M | $987.3K | $1.72M | $1.60M | $1.02M | - |
| Current assets | $45.76M | $39.79M | $24.18M | $14.72M | $16.55M | $10.84M | - |
| Total assets | $85.19M | $61.77M | $46.56M | $37.26M | $36.41M | $25.20M | - |
| Current liabilities | $26.31M | $16.45M | $9.61M | $6.65M | $7.53M | $11.70M | - |
| Short-term debt | $1.08M | $461.8K | $419.6K | $2.14M | $448.0K | $1.23M | - |
| Long-term debt | $842.8K | $970.1K | $871.4K | $189.8K | $2.17M | $2.48M | - |
| Total debt | $1.92M | $1.43M | $1.29M | $2.33M | $2.62M | $3.71M | - |
| Total liabilities | $27.19M | $17.42M | $10.57M | $7.16M | $9.88M | $14.18M | - |
| Shareholders' equity | $57.55M | $43.91M | $35.98M | $30.09M | $26.53M | $11.02M | $7.26M |
Cash flow
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $141.1K | -$7.72M | -$616.9K | -$187.1K | $4.05M | $2.64M | $7.10M |
| Capital expenditures | $6.8K | $7.0K | $61.9K | $27.7K | $51.9K | $31.9K | $213.6K |
| Free cash flow | $134.3K | -$7.73M | -$678.8K | -$214.8K | $4.00M | $2.61M | $6.89M |
| Investing cash flow | -$10.00M | -$15.7K | -$1.19M | -$3.06M | -$7.44M | -$3.00M | -$8.43M |
| Financing cash flow | $15.45M | $8.76M | $1.16M | $2.26M | $5.35M | $112.5K | $804.7K |
| Stock-based compensation | $1.39M | $1.32M | $349.4K | $170.9K | $422.2K | $211.1K | - |
| Depreciation and amortization | $1.09M | $1.11M | $949.5K | $215.6K | $228.5K | $230.6K | $226.6K |
Key ratios
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -21.7% | -19.2% | -1.3% | 17.3% | 39.9% | 11.1% | - |
| Net income growth, YoY | - | -91.3% | -26.3% | 35.9% | 51.7% | 17.6% | - |
| EPS growth, YoY | - | - | -32.7% | 9.3% | 17.2% | 16.0% | - |
| Gross margin | 20.8% | 29.8% | 29.9% | 31.5% | 27.9% | 28.6% | 32.2% |
| Operating margin | -8.7% | 7.9% | 20.1% | 22.1% | 21.2% | 19.0% | 19.4% |
| Net margin | -10.7% | 1.7% | 15.6% | 20.9% | 18.0% | 16.6% | 15.7% |
| Free cash flow margin | 0.7% | -32.4% | -2.3% | -0.7% | 15.7% | 14.3% | 42.0% |
| Return on equity | -3.5% | 0.9% | 12.8% | 20.7% | 17.3% | 27.5% | 35.4% |
| Return on assets | -2.3% | 0.6% | 9.9% | 16.7% | 12.6% | 12.0% | - |
| Current ratio | 1.74 | 2.42 | 2.52 | 2.21 | 2.20 | 0.93 | - |
| Debt to equity | 0.03 | 0.03 | 0.04 | 0.08 | 0.10 | 0.34 | - |
Source: XBRL data Bon Natural Life Limited files with the SEC, latest filing dated Jan 23, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-10, first reported Jan 28, 2025; 1-for-25, first reported Jan 23, 2026.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
BON peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| BON | $18.67M | -21.7% | -$1.99M | -10.7% | $9.0M |
| PM | $43.14B | +7.9% | $10.71B | 24.8% | $301.01B |
| BTI | £25.61B | -1.0% | £7.76B | 30.3% | $129.81B |
| MO | $23.52B | +0.5% | $8.12B | 34.5% | $126.11B |
| DFTX | - | - | -$337.48M | - | $4.76B |
| RGC | - | - | -$11.70M | - | $2.79B |
| TRLV | $1.08B | -9.1% | -$445.60M | -41.2% | $2.12B |
| RLX | CN¥3.96B | +44.0% | CN¥921.87M | 23.3% | $1.94B |
| CRON | $271.85M | +54.3% | $63.36M | 23.3% | $1.30B |
BON FAQ
9 questionsWhat is BON revenue?
Bon Natural Life Limited (BON) reported $18.67M of revenue for fiscal 2025 (ended Sep 30, 2025). That is down 21.7% from the year before.Is BON profitable?
No. Bon Natural Life Limited reported a net loss of $1.99M for fiscal 2025 (ended Sep 30, 2025).How much cash and debt does BON have?
Bon Natural Life Limited reported $6.27M in cash and cash equivalents and $1.92M of debt on its most recent balance sheet in SEC filings.How fast is BON revenue growing?
Bon Natural Life Limited's revenue changed -21.7% in fiscal 2025, to $18.67M. Its compound annual growth rate was +0.5% over 5 years.What is BON gross margin?
Bon Natural Life Limited's gross profit was $3.88M on $18.67M of revenue for fiscal 2025 (ended Sep 30, 2025), a gross margin of 20.8%.What is BON free cash flow?
Bon Natural Life Limited generated $134.3K of free cash flow for fiscal 2025 (ended Sep 30, 2025), which is operating cash flow of $141.1K less capital expenditures.What is BON earnings per share?
Diluted earnings per share were -$0.72 for fiscal 2025 (ended Sep 30, 2025), from SEC filings, restated for any stock split those filings show.When did BON last report financial results?
The latest statements here come from Bon Natural Life Limited's 20-F filed on Jan 23, 2026, covering the period ended Sep 30, 2025.Where does this BON financial data come from?
Quantisnow builds these statements from the structured XBRL data Bon Natural Life Limited files with the SEC. It is provided for information only and is not investment advice.